Literature DB >> 220654

Tardive dyskinesia: a clinical test of the supersensitivity hypothesis.

M B Bowers, D Moore, D Tarsy.   

Abstract

Patients with tardive dyskinesia showed no significant difference in CSF HVA when compared with groups of schizophrenic or depressives. CSF cAMP in the tardive dyskinesia group was significantly lower when compared to schizophrenics but not depressives. These results do not support a dopamine-receptor supersensitivity hypothesis in permanent tardive dyskinesia.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 220654     DOI： 10.1007/bf00426727

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


  46 in total

1.  Time-dependent effects of phenothiazines on dopamine turnover in psychiatric patients.

Authors:  R M Post; F K Goodwin
Journal:  Science       Date:  1975-10-31       Impact factor: 47.728

2.  The occurrence, distribution and physiological role of catecholamines in the nervous system.

Authors:  A CARLSSON
Journal:  Pharmacol Rev       Date:  1959-06       Impact factor: 25.468

Review 3.  Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).

Authors:  O Hornykiewicz
Journal:  Br Med Bull       Date:  1973-05       Impact factor: 4.291

4.  Cholinergic and dopaminergic mechanisms in Huntington's chorea.

Authors:  S M Aquilonius; R Sjöström
Journal:  Life Sci I       Date:  1971-04-01

5.  Stereotaxic mapping of the monoamine pathways in the rat brain.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

6.  Central monoamine metabolism in man. Effect of putative dopamine receptor agonists and antagonists.

Authors:  T N Chase
Journal:  Arch Neurol       Date:  1973-11

Review 7.  Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature.

Authors:  G E Crane
Journal:  Am J Psychiatry       Date:  1968-02       Impact factor: 18.112

8.  The effect of L-dopa on monoamine metabolites in Parkinson's disease.

Authors:  M H van Woert; M B Bowers
Journal:  Experientia       Date:  1970

9.  Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.

Authors:  R Olsson; B E Roos
Journal:  Nature       Date:  1968-08-03       Impact factor: 49.962

10.  CYCLIC AMP/*SECRETl cyclic AMP into push-pull perfusates in freely moving rats.

Authors:  J Korf; P H Boer; D Fekkes
Journal:  Brain Res       Date:  1976-09-03       Impact factor: 3.252
View more
  4 in total

1.  Effect of adjuvant reserpine treatment on catecholamine metabolism in schizophrenic patients under long-term neuroleptic treatment.

Authors:  G Bagdy; A Perenyi; E Frecska; A Seregi; M I Fekete; L Tothfalusi; K Magyar; A Bela; M Arato
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

2.  Regional homovanillic acid levels and oral movements in rats following chronic haloperidol treatment.

Authors:  S A Kolenik; F J Hoffman; M B Bowers
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Effects of discontinuous drug administration on the development of dopamine receptor supersensitivity during chronic trifluoperazine or cis-flupenthixol administration to rats.

Authors:  K Murugaiah; A Theodorou; A Clow; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 4.  Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.

Authors:  Karla Soares-Weiser; John Rathbone; Yusuke Ogawa; Kiyomi Shinohara; Hanna Bergman
Journal:  Cochrane Database Syst Rev       Date:  2018-03-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.